Periscope Capital »

Carmell Therapeutics Corp - US shares owned by Periscope Capital

Quarter-by-quarter ownership of Carmell Therapeutics Corp - US (CTCXW) shares owned by Periscope Capital from 13F filings

Historical chart of Periscope Capital investment in Carmell Therapeutics Corp - US

Tip: Access up to 7 years of quarterly data

All positions including Carmell Therapeutics Corp - US held by Periscope Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Carmell Therapeutics Corp - US by Periscope Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $32k 196k 0.17
2023-12-31 $55k 240k 0.23
2023-09-30 $59k 243k 0.24

More positions owned by Periscope Capital

Ishares Tr Iboxx Inv Cp Etf Put Option (LQD)
Ares Acquisition Corp Ii Shs Class A (AACT)
Silverbox Corp Iii Com Cl A (SBXC)
Concord Acquisition Corp Ii Com Cl A (CNDA)
Esh Acquisition Corp (ESHA)
Nabors Energy Transition Cor Cl A (NETD)
Legato Merger Corp Iii Unit 99/99/9999
Haymaker Acquisition Corp Iv Class A (HYAC)
Agriculture & Nat Sol Acq Shs Cl A
Inflection Pt Acquisitn Crp Cl A Ord Shs (IPXX)
Rigel Resource Acq Corp Cl A Ord Shs (RRAC)
99 Acquisition Group Cl A (NNAG)
Valuence Merger Corp I Class A Ord Shs (VMCA)
Spring Valley Acquistn Corp Class A Ord (SVII)
Tristar Acquisition I Corp Cl A Ord Shs (TRIS)

View all positions for Periscope Capital

Top funds holding Carmell Therapeutics Corp - US

Antara Capital
UBS O'Connor
Balyasny Asset Management
OZ Management
Periscope Capital
Millennium Management
Highbridge Capital Management
Exos TFP Holdings
Exos Asset Management
Citadel Advisors
CNH Partners
Walleye Trading Advisors
Cowen And Company
Saba Capital Management
Whitebox Advisors

View all funds holding Carmell Therapeutics Corp - US